iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients

Reuters03-30

iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients

iRhythm reported retrospective analyses presented at ACC 2026 showing high rates of clinically actionable arrhythmias detected with its 14-day Zio ambulatory ECG monitoring across cardiovascular-kidney-metabolic risk groups.
In a cohort of 657,147 monitored individuals, age-adjusted clinically actionable arrhythmias were found in 48% of patients with chronic kidney disease, versus 35% in patients with neither chronic kidney disease nor diabetes.
Separate ACC 2026 analysis of 162,531 monitored individuals linked higher body weight to higher atrial fibrillation detection, rising to 6.5% in severe obesity from 4.5% in normal or underweight patients.
Launch of iRhythm Academy expanded clinician education offerings focused on ambulatory cardiac monitoring.
Upcoming MyZio mobile app update adds Spanish-language functionality to support patient use during monitoring.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603300805PRIMZONEFULLFEED9680395) on March 30, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2623731798?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 20:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623731798","market":"nz","top_or_hot":-1,"title":"iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          iRhythm reported retrospective analyses presented at ACC 2026 showing high rates of clinically actionable arrhythmias detected with its 14-day Zio ambulatory ECG monitoring across cardiovascular-kidney-metabolic risk groups.\n        </li>\n<li>\n          In a cohort of 657,147 monitored individuals, age-adjusted clinically actionable arrhythmias were found in 48% of patients with chronic kidney disease, versus 35% in patients with neither chronic kidney disease nor diabetes.\n        </li>\n<li>\n          Separate ACC 2026 analysis of 162,531 monitored individuals linked higher body weight to higher atrial fibrillation detection, rising to 6.5% in severe obesity from 4.5% in normal or underweight patients.\n        </li>\n<li>\n          Launch of iRhythm Academy expanded clinician education offerings focused on ambulatory cardiac monitoring.\n        </li>\n<li>\n          Upcoming MyZio mobile app update adds Spanish-language functionality to support patient use during monitoring.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603300805PRIMZONEFULLFEED9680395) on March 30, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-30 20:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          iRhythm reported retrospective analyses presented at ACC 2026 showing high rates of clinically actionable arrhythmias detected with its 14-day Zio ambulatory ECG monitoring across cardiovascular-kidney-metabolic risk groups.\n        </li>\n<li>\n          In a cohort of 657,147 monitored individuals, age-adjusted clinically actionable arrhythmias were found in 48% of patients with chronic kidney disease, versus 35% in patients with neither chronic kidney disease nor diabetes.\n        </li>\n<li>\n          Separate ACC 2026 analysis of 162,531 monitored individuals linked higher body weight to higher atrial fibrillation detection, rising to 6.5% in severe obesity from 4.5% in normal or underweight patients.\n        </li>\n<li>\n          Launch of iRhythm Academy expanded clinician education offerings focused on ambulatory cardiac monitoring.\n        </li>\n<li>\n          Upcoming MyZio mobile app update adds Spanish-language functionality to support patient use during monitoring.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603300805PRIMZONEFULLFEED9680395) on March 30, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BN0W2V16.EUR","symbol_name":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL5l1R3Q:1","article_id":"2623731798","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2623731798","pubTimestamp":1774872693,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"iRhythm reported retrospective analyses presented at ACC 2026 showing high rates of clinically actionable arrhythmias detected with its 14-day Zio ambulatory ECG monitoring across cardiovascular-kidney-metabolic risk groups.In a cohort of 657,147 monitored individuals, age-adjusted clinically actionable arrhythmias were found in 48% of patients with chronic kidney disease, versus 35% in patients with neither chronic kidney disease nor diabetes.Separate ACC 2026 analysis of 162,531 monitored individuals linked higher body weight to higher atrial fibrillation detection, rising to 6.5% in severe obesity from 4.5% in normal or underweight patients.Launch of iRhythm Academy expanded clinician education offerings focused on ambulatory cardiac monitoring.Upcoming MyZio mobile app update adds Spanish-language functionality to support patient use during monitoring.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","IRTC":"Irhythm Technologies Inc.","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","BK4585":"ETF&股票定投概念","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4112":"金融交易所和数据","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4588":"碎股","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","NDAQ":"纳斯达克OMX交易所","BK4563":"昨日强势股","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","BK4082":"医疗保健设备"},"translate_title":"iRhythm ACC数据显示Zio ECG监测在CKD、糖尿病患者中发现可操作的心律失常","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"IRTC":0.9},"content_text":"iRhythm ACC data show Zio ECG monitoring finds actionable arrhythmias in CKD, diabetes patients\n    \n\n\n          iRhythm reported retrospective analyses presented at ACC 2026 showing high rates of clinically actionable arrhythmias detected with its 14-day Zio ambulatory ECG monitoring across cardiovascular-kidney-metabolic risk groups.\n        \n\n          In a cohort of 657,147 monitored individuals, age-adjusted clinically actionable arrhythmias were found in 48% of patients with chronic kidney disease, versus 35% in patients with neither chronic kidney disease nor diabetes.\n        \n\n          Separate ACC 2026 analysis of 162,531 monitored individuals linked higher body weight to higher atrial fibrillation detection, rising to 6.5% in severe obesity from 4.5% in normal or underweight patients.\n        \n\n          Launch of iRhythm Academy expanded clinician education offerings focused on ambulatory cardiac monitoring.\n        \n\n          Upcoming MyZio mobile app update adds Spanish-language functionality to support patient use during monitoring.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603300805PRIMZONEFULLFEED9680395) on March 30, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2623731798","isCrawlerRequest":true}